Medtech M&A has remained strong through the first half of 2026. This and more in this week’s life sciences update. … READ MORE >
biopharma
5 things to know in life sciences: Week of June 1, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 25, 2026
AI adoption in medtech is rapidly accelerating. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of May 11, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 4, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of April 27, 2026
Regulators have introduced a new pathway designed to accelerate Medicare coverage decisions for innovative medical devices. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of April 20, 2026
The FDA has advanced a plan to reduce animal testing. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of April 13, 2026
Biotech IPOs begin to pick back up in Q2. This and more in this week’s life sciences update. … READ MORE >
Biopharma markets thaw: M&A and fundraising accelerate
Dealmaking and capital formation in the biopharma sector are gaining momentum. … READ MORE >
New 100% tariff announced for branded pharmaceutical products
To evaluate the impact of applying most favored nation pricing, companies should look at global sales strategies, gross-to-net pricing and existing transfer pricing arrangements. … READ MORE >